Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Anderson

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|October 20, 2022
Fluorine labelling of therapeutic human tolerogenic dendritic cells for <sup>19</sup>F-magnetic resonance imagingFiona Cooke, Mary Neal, Matthew J Wood, et al.
Annals of the Rheumatic Diseases|February 3, 2026
Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritisIoana Nicorescu, Amanda Thomson, George Merces, et al.
Implementation Science : IS|August 22, 2018
A practice change intervention to improve antenatal care addressing alcohol consumption by women during pregnancy: research protocol for a randomised stepped-wedge cluster trialMelanie Kingsland, Emma Doherty, Amy E Anderson, et al.
Cancer Research|April 18, 2024
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T CellsDana Piovesan, Amber E de Groot, Soonweng Cho, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Gastroenterology|April 2, 2017
Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver FailureWafa Khamri, Robin D Abeles, Tie Zheng Hou, et al.
Molecular Cancer Therapeutics|May 27, 2024
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid TumorsAmy E Anderson, Kaustubh Parashar, Ke Jin, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Elife|May 8, 2015
RIPOSTE: a framework for improving the design and analysis of laboratory-based researchNicholas Gd Masca, Elizabeth Ma Hensor, Victoria R Cornelius, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 20, 2022
Fluorine labelling of therapeutic human tolerogenic dendritic cells for <sup>19</sup>F-magnetic resonance imagingFiona Cooke, Mary Neal, Matthew J Wood, et al.
Annals of the Rheumatic Diseases|February 3, 2026
Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritisIoana Nicorescu, Amanda Thomson, George Merces, et al.
Implementation Science : IS|August 22, 2018
A practice change intervention to improve antenatal care addressing alcohol consumption by women during pregnancy: research protocol for a randomised stepped-wedge cluster trialMelanie Kingsland, Emma Doherty, Amy E Anderson, et al.
Cancer Research|April 18, 2024
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T CellsDana Piovesan, Amber E de Groot, Soonweng Cho, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Gastroenterology|April 2, 2017
Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver FailureWafa Khamri, Robin D Abeles, Tie Zheng Hou, et al.
Molecular Cancer Therapeutics|May 27, 2024
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid TumorsAmy E Anderson, Kaustubh Parashar, Ke Jin, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Elife|May 8, 2015
RIPOSTE: a framework for improving the design and analysis of laboratory-based researchNicholas Gd Masca, Elizabeth Ma Hensor, Victoria R Cornelius, et al.
Pageof 8